Yasuyuki Gen

Genome-wide DNA methylation analysis in hepatocellular carcinoma.

Yuji Naito, Atsushi Umemura, Shinji Tanaka, 2016, Oncology reports.

Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma

S. Arii, Y. Naito, T. Yoshikawa, 2012, International journal of oncology.

PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.

M. Taniwaki, T. Okanoue, S. Arii, 2010, Cancer genetics and cytogenetics.

miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway.

J. Inazawa, H. Harada, K. Tanimoto, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway

T. Yoshikawa, Taichiro Nishikawa, K. Yasui, 2013, Cancer science.

SOX 2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT ⁄ mammalian target of rapamycin complex 1 signaling pathway

T. Yoshikawa, Taichiro Nishikawa, K. Yasui, 2013 .

EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma

M. Moriguchi, S. Arii, O. Dohi, 2015, Cancer science.

Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma

M Taniwaki, N Wakabayashi, M. Taniwaki, 2009, Oncogene.